Advanced HER2-positive breast cancer: Overcoming treatment resistance

被引：0
|
作者：
Rimawi, M. [1 ]
机构：
[1] Baylor Coll Med, Houston, TX 77030 USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-ES1-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
ES1-3
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Preoperative treatment of HER2-positive breast cancer
    Wysocki, Piotr J.
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2020, 16 (02): : 69 - 74
  • [22] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Danijela Jelovac
    Antonio C. Wolff
    Current Treatment Options in Oncology, 2012, 13 : 230 - 239
  • [23] Progression and treatment of HER2-positive breast cancer
    Davoli, April
    Hocevar, Barbara A.
    Brown, Thomas L.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 65 (04) : 611 - 623
  • [24] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Jelovac, Danijela
    Wolff, Antonio C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 230 - 239
  • [25] Treatment strategy for HER2-positive breast cancer
    Hirofumi Mukai
    International Journal of Clinical Oncology, 2010, 15 : 335 - 340
  • [26] INDIVIDUALIZED TREATMENT FOR HER2-POSITIVE BREAST CANCER
    Takano, Toshimi
    ANNALS OF ONCOLOGY, 2014, 25
  • [27] Systemic Therapies for HER2-Positive Advanced Breast Cancer
    Angelis, Vasileios
    Okines, Alicia F. C.
    CANCERS, 2024, 16 (01)
  • [28] Two Drugs for Advanced HER2-Positive Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1611): : 182 - 184
  • [29] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [30] Preclinical and Basic Research Strategies for Overcoming Resistance to Targeted Therapies in HER2-Positive Breast Cancer
    Cao, Yi
    Li, Yunjin
    Liu, Ruijie
    Zhou, Jianhua
    Wang, Kuansong
    CANCERS, 2023, 15 (09)
12345